Charles Gayer
Board Member
Biocryst Pharmaceuticals Inc (BCRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Charles Gayer
Charles Gayer is recorded as CEO and Board Member at Biocryst Pharmaceuticals Inc (BCRX). The proxy statement of Biocryst Pharmaceuticals Inc reports total compensation of $9,627,868 for Charles Gayer in fiscal 2025, including a base salary of $609,397. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-01-01–present
-
Current
Start not stated–present
-
Biocryst Pharmaceuticals Inc (BCRX)
Proxy statement
Start not stated–2025-04-24
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Biocryst Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Charlie Gayer CEO, Board Member
- Jon P. Stonehouse CEO, CFO, Chief Accounting Officer, Board Member
- Vincent J. Milano Chairman, Board Member
- Anthony Doyle CFO
- Babar Ghias CFO, Chief Accounting Officer
- Thomas R. Staab II CFO
- A. Machelle Sanders Board Member
- Alan G. Levin Board Member
- Amy E. McKee Board Member
- Amy E. McKee, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biocryst Pharmaceuticals Inc (BCRX) | President and Chief Executive Officer; Former Chief Commercial Officer | $609,397 | $9,627,868 |
| 2024 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Commercial Officer | $544,830 | $3,375,210 |
| 2023 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Commercial Officer | $495,300 | $1,738,544 |
| 2022 | Biocryst Pharmaceuticals Inc (BCRX) | Chief Commercial Officer | $448,700 | $2,198,862 |
Recent activity
No call appearances or filed executive changes recorded yet.